What they were paid
Vanda Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $115,000 | $259,998 | $0 | $0 | $374,998 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vanda Pharmaceuticals Inc. DEF 14A filed April 23, 2026, accession 0001628280-26-026893, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Vanda Pharmaceuticals pays directors a $50,000 cash retainer and $390,000 in equity.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the Vanda Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anne Sempowski Ward | Independent Director | $344,998 |
| Charles C. Duncan | Independent Director | $0 |
| Mihael H. Polymeropoulos | Chair of the Board | $0 |
| Phaedra S. Chrousos | Independent Director | $339,998 |
| Stephen Ray Mitchell | Independent Director | $317,498 |
| Tage Honoré | Independent Director | $327,498 |
The full Vanda Pharmaceuticals compensation record
free company briefThis page is one director within Vanda Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat